(CIDRAP News) – Federal officials announced yesterday that $1 billion worth of grants and tax credits will be awarded to thousands of small biotechnology companies to support the development of new medical therapies, including a number of products for infectious diseases.
Editor's Note: This is the first of a series of articles reviewing the world's experience with pandemic H1N1 influenza and what we've learned in the past year. Look for further installments in the days to come.
(CIDRAP News) A year's experience with the 2009 H1N1 influenza virus has underscored the endless unpredictability of flu.
(CIDRAP News) A multi-national team of researchers has applied a new genomic tool to a 50-year-old bacterial foe, using minute mutations to track the spread of drug-resistant staph both across continents and within a single hospital.